Smith & Nephew PLC (NYSE:SNN) saw a large growth in short interest during the month of October. As of October 31st, there was short interest totalling 1,455,006 shares, a growth of 45.3% from the October 14th total of 1,001,407 shares. Based on an average daily trading volume, of 426,025 shares, the days-to-cover ratio is presently 3.4 days.

Several large investors have recently modified their holdings of SNN. JPMorgan Chase & Co. raised its stake in shares of Smith & Nephew PLC by 427.0% in the first quarter. JPMorgan Chase & Co. now owns 56,617 shares of the company’s stock worth $1,886,000 after buying an additional 45,874 shares in the last quarter. Goldman Sachs Group Inc. increased its position in Smith & Nephew PLC by 21.7% in the first quarter. Goldman Sachs Group Inc. now owns 149,657 shares of the company’s stock valued at $4,986,000 after buying an additional 26,708 shares during the last quarter. Envestnet Asset Management Inc. increased its position in Smith & Nephew PLC by 6.7% in the first quarter. Envestnet Asset Management Inc. now owns 120,863 shares of the company’s stock valued at $4,027,000 after buying an additional 7,615 shares during the last quarter. Curbstone Financial Management Corp increased its position in Smith & Nephew PLC by 1.0% in the second quarter. Curbstone Financial Management Corp now owns 35,550 shares of the company’s stock valued at $1,220,000 after buying an additional 350 shares during the last quarter. Finally, Augustine Asset Management Inc. increased its position in Smith & Nephew PLC by 2.1% in the second quarter. Augustine Asset Management Inc. now owns 98,515 shares of the company’s stock valued at $3,381,000 after buying an additional 2,005 shares during the last quarter. 5.86% of the stock is owned by hedge funds and other institutional investors.

SNN has been the subject of a number of recent research reports. Barclays PLC downgraded Smith & Nephew PLC from an “overweight” rating to an “equal weight” rating in a research report on Wednesday, August 10th. Beaufort Securities restated a “hold” rating on shares of Smith & Nephew PLC in a research report on Wednesday, August 10th. Zacks Investment Research upgraded Smith & Nephew PLC from a “sell” rating to a “hold” rating in a research report on Saturday, September 3rd. Berenberg Bank downgraded Smith & Nephew PLC from a “buy” rating to a “hold” rating in a research report on Thursday, October 6th. Finally, Deutsche Bank AG restated a “hold” rating on shares of Smith & Nephew PLC in a research report on Wednesday, October 26th. Eight equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. The stock presently has an average rating of “Hold” and an average target price of $37.00.

Smith & Nephew PLC (NYSE:SNN) opened at 27.73 on Friday. The stock has a market capitalization of $12.40 billion, a PE ratio of 34.92 and a beta of 0.81. Smith & Nephew PLC has a 1-year low of $26.97 and a 1-year high of $36.11. The stock’s 50 day moving average price is $29.82 and its 200 day moving average price is $32.69.

The firm also recently declared a dividend, which was paid on Tuesday, October 25th. Investors of record on Friday, October 7th were paid a dividend of $0.236 per share. The ex-dividend date was Wednesday, October 5th.

Smith & Nephew PLC Company Profile

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. The Company offers various product franchises, which include Knee implants, Hip implants, Sports Medicine Joint Repair, Arthroscopy Enabling Technologies, Trauma and Extremities, Other Surgical Businesses, Advanced Wound Care, Advanced Wound Devices and Advanced Wound Bioactives.

5 Day Chart for NYSE:SNN

Receive News & Stock Ratings for Smith & Nephew PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew PLC and related stocks with our FREE daily email newsletter.